Advances in cardiovascular research during the past two decades have resulted in an
improved understanding of the chain of events that lead to end-stage coronary artery …

A ngiotensin-converting enzyme (ACE) inhibitors are commonly used drugs in the
management of a variety of cardiovascular diseases. They are effective antihypertensive …

This is a metaanalysis of all available studies as of December 1990 that have evaluated the
effect of antihypertensive pharmacologic therapy on left ventricular structure examined by …

This review summarizes emerging evidence that supports the notion of a separate brain
renin-angiotensin system (RAS) complete with the necessary precursors and enzymes for …

A double-blind, positively controlled, forced dose titration study comparing the efficacy and
safety of atenolol, captopril, and verapamil sustained release as single agents in the …

Considerable evidence now indicates that a separate and distinct renin-angiotensin system
(RAS) is present within the brain. The necessary precursors and enzymes required for the …

The discovery of at least four angiotensin receptor subtypes, three of which are distributed in
the brain as well as peripheral tissues, and the availability of nonpeptide angiotensin …

OBJECTIVE: To review the incidence, pathophysiology, significance, diagnosis, and
treatment of heart failure with normal systolic function in older patients DATA SOURCE …

Captopril is an orally active inhibitor of angiotensin-converting enzyme (ACE) and has been
widely studied in the treatment of patients with mild to moderate essential hypertension …

To date, there is no universally accepted therapy for viral myocarditis. We investigated the
effect of the angiotensin converting enzyme inhibitor captopril on both early and late phases …